American BriVision (Holding) Corporation (MTOO) financial statements (2021 and earlier)

Company profile

Business Address 44370 OLD WARM SPRINGS BLVD.
FREMONT, CA 94538
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 40205174
Cash and cash equivalents 40205174
Receivables 402,550 
Prepaid expense 0  
Other undisclosed current assets 16  
Total current assets: 962,755174
Noncurrent Assets
Deposits noncurrent assets   4
Total noncurrent assets:   4
TOTAL ASSETS: 962,755177
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 44924 
Accrued liabilities 5  
Employee-related liabilities 44424 
Debt 300  
Due to related parties 250  
Other undisclosed current liabilities 4,569  
Total current liabilities: 5,56824 
Noncurrent Liabilities
Liabilities, other than long-term debt 250  
Due to related parties 250  
Other undisclosed noncurrent liabilities 27  
Total noncurrent liabilities: 277  
Other undisclosed liabilities  4,1246,556
Total liabilities: 5,8464,1486,556
Stockholders' equity
Stockholders' equity attributable to parent (5,749)(1,393)(6,379)
Common stock 214214211
Additional paid in capital 13,91513,7894,733
Accumulated deficit (19,878)(15,395)(11,323)
Total stockholders' equity: (5,749)(1,393)(6,379)
TOTAL LIABILITIES AND EQUITY: 962,755177

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
9/30/2017
9/30/2016
Cost of goods and services sold (1)  
Gross profit: (1) (0)
Operating expenses (1,394)(3,858)(10,997)
Other undisclosed operating income (loss) 1(138) 
Operating loss: (1,394)(3,996)(10,997)
Nonoperating expense (2,706)(75)(10)
Interest and debt expense (156)(75)(10)
Loss from continuing operations before equity method investments, income taxes: (4,255)(4,146)(11,017)
Other undisclosed income from continuing operations before income taxes 1567510
Loss from continuing operations before income taxes: (4,099)(4,071)(11,007)
Income tax expense (2)(1)(1)
Net loss available to common stockholders, diluted: (4,101)(4,072)(11,008)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
9/30/2017
9/30/2016
Net loss: (4,101)(4,072)(11,008)
Comprehensive loss, net of tax, attributable to parent: (4,101)(4,072)(11,008)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: